The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Metabolic characterization of inflammatory breast cancer (IBC) with baseline FDG-PET/CT: Relationship with histopathology, hormone receptor status, and pathologic response after neoadjuvant chemotherapy.
Trisha Youn
No relevant relationships to disclose
Heather A. Jacene
No relevant relationships to disclose
Pamela Dipiro
No relevant relationships to disclose
Yoko Tanaka
No relevant relationships to disclose
Jennifer Ruth Bellon
No relevant relationships to disclose
Faina Nakhlis
No relevant relationships to disclose
Judith Hirshfield-Bartek
No relevant relationships to disclose
Eren Yeh
No relevant relationships to disclose
Beth Overmoyer
No relevant relationships to disclose